[HTML] frontiersin.org

[HTML][HTML] The Interplay Between Epigenetic Regulation and CD8+ T Cell Differentiation/Exhaustion for T Cell Immunotherapy

WK Wong, B Yin, CYK Lam, Y Huang, J Yan… - Frontiers in cell and …, 2022 - frontiersin.org
Effective immunotherapy treats cancers by eradicating tumourigenic cells by activated
tumour antigen-specific and bystander CD8+ T-cells. However, T-cells can gradually lose …
被引用次数：16 相关文章

[引用][C] The Interplay Between Epigenetic Regulation and CD8+ T Cell Differentiation/Exhaustion for T Cell Immunotherapy

WK Wong, B Yin, K Lam, Y Huang, J Yan… - Frontiers in Cell and …, 2022 - hub.hku.hk
HKU Scholars Hub: The Interplay Between Epigenetic Regulation and CD8+ T Cell
Differentiation/Exhaustion for T Cell Immunotherapy Skip navigation HKU Login Guest Login …

The Interplay Between Epigenetic Regulation and CD8+ T Cell Differentiation/Exhaustion for T Cell Immunotherapy

WK Wong, B Yin, CYK Lam, Y Huang… - Frontiers in cell …, 2022 - pubmed.ncbi.nlm.nih.gov
Effective immunotherapy treats cancers by eradicating tumourigenic cells by activated
tumour antigen-specific and bystander CD8+ T-cells. However, T-cells can gradually lose …

The interplay between epigenetic regulation and CD8+ T cell differentiation/exhaustion for T cell immunotherapy

WK Wong, B Yin, CYK Lam, Y Huang… - Frontiers in cell and …, 2022 - ira.lib.polyu.edu.hk
Effective immunotherapy treats cancers by eradicating tumourigenic cells by activated
tumour antigen-specific and bystander CD8+ T-cells. However, T-cells can gradually lose …

The Interplay Between Epigenetic Regulation and CD8+ T Cell Differentiation/Exhaustion for T Cell Immunotherapy.

WK Wong, B Yin, CYK Lam, Y Huang, J Yan… - Frontiers in Cell and …, 2022 - europepmc.org
Effective immunotherapy treats cancers by eradicating tumourigenic cells by activated
tumour antigen-specific and bystander CD8+ T-cells. However, T-cells can gradually lose …

The Interplay Between Epigenetic Regulation and CD8+ T Cell Differentiation/Exhaustion for T Cell Immunotherapy

WK Wong, B Yin, CYK Lam, Y Huang… - Frontiers in Cell and …, 2022 - research.polyu.edu.hk
Effective immunotherapy treats cancers by eradicating tumourigenic cells by activated
tumour antigen-specific and bystander CD8+ T-cells. However, T-cells can gradually lose …
[HTML] nih.gov

[HTML][HTML] The Interplay Between Epigenetic Regulation and CD8+ T Cell Differentiation/Exhaustion for T Cell Immunotherapy

WK Wong, B Yin, CYK Lam, Y Huang… - Frontiers in Cell and …, 2021 - ncbi.nlm.nih.gov
Effective immunotherapy treats cancers by eradicating tumourigenic cells by activated
tumour antigen-specific and bystander CD8+ T-cells. However, T-cells can gradually lose …

The Interplay Between Epigenetic Regulation and CD8+ T Cell Differentiation/Exhaustion for T Cell Immunotherapy

WK Wong, B Yin, CYK Lam, Y Huang, J Yan, Z Tan… - 2022 - agris.fao.org
Effective immunotherapy treats cancers by eradicating tumourigenic cells by activated
tumour antigen-specific and bystander CD8+ T-cells. However, T-cells can gradually lose …